These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 23363527
1. Facile incorporation of aggregation-induced emission materials into mesoporous silica nanoparticles for intracellular imaging and cancer therapy. Zhang X, Zhang X, Wang S, Liu M, Zhang Y, Tao L, Wei Y. ACS Appl Mater Interfaces; 2013 Mar; 5(6):1943-7. PubMed ID: 23363527 [Abstract] [Full Text] [Related]
2. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Lee JE, Lee N, Kim T, Kim J, Hyeon T. Acc Chem Res; 2011 Oct 18; 44(10):893-902. PubMed ID: 21848274 [Abstract] [Full Text] [Related]
3. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles. Tsai CH, Vivero-Escoto JL, Slowing II, Fang IJ, Trewyn BG, Lin VS. Biomaterials; 2011 Sep 18; 32(26):6234-44. PubMed ID: 21684000 [Abstract] [Full Text] [Related]
4. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells. Morelli C, Maris P, Sisci D, Perrotta E, Brunelli E, Perrotta I, Panno ML, Tagarelli A, Versace C, Casula MF, Testa F, Andò S, Nagy JB, Pasqua L. Nanoscale; 2011 Aug 18; 3(8):3198-207. PubMed ID: 21725561 [Abstract] [Full Text] [Related]
5. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging. Shanta Singh N, Kulkarni H, Pradhan L, Bahadur D. Nanotechnology; 2013 Feb 15; 24(6):065101. PubMed ID: 23324398 [Abstract] [Full Text] [Related]
6. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery. Chen Z, Li X, He H, Ren Z, Liu Y, Wang J, Li Z, Shen G, Han G. Colloids Surf B Biointerfaces; 2012 Jun 15; 95():274-8. PubMed ID: 22494670 [Abstract] [Full Text] [Related]
7. A facile surface modification strategy for fabrication of fluorescent silica nanoparticles with the aggregation-induced emission dye through surface-initiated cationic ring opening polymerization. Huang L, Yang S, Chen J, Tian J, Huang Q, Huang H, Wen Y, Deng F, Zhang X, Wei Y. Mater Sci Eng C Mater Biol Appl; 2019 Jan 01; 94():270-278. PubMed ID: 30423709 [Abstract] [Full Text] [Related]
8. Stable mesoporous silica nanoparticles incorporated with MoS2 and AIE for targeted fluorescence imaging and photothermal therapy of cancer cells. Wang J, Xu M, Wang K, Chen Z. Colloids Surf B Biointerfaces; 2019 Feb 01; 174():324-332. PubMed ID: 30472618 [Abstract] [Full Text] [Related]
9. Surfactant modification of aggregation-induced emission material as biocompatible nanoparticles: facile preparation and cell imaging. Zhang X, Zhang X, Wang S, Liu M, Tao L, Wei Y. Nanoscale; 2013 Jan 07; 5(1):147-50. PubMed ID: 23154790 [Abstract] [Full Text] [Related]
10. Fabrication of fluorescent silica nanoparticles with aggregation-induced emission luminogens for cell imaging. Chen S, Lam JW, Tang BZ. Methods Mol Biol; 2013 Jan 07; 991():163-9. PubMed ID: 23546668 [Abstract] [Full Text] [Related]
11. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers. Yang Y, Song W, Wang A, Zhu P, Fei J, Li J. Phys Chem Chem Phys; 2010 May 07; 12(17):4418-22. PubMed ID: 20407714 [Abstract] [Full Text] [Related]
12. The packaging of siRNA within the mesoporous structure of silica nanoparticles. Li X, Xie QR, Zhang J, Xia W, Gu H. Biomaterials; 2011 Dec 07; 32(35):9546-56. PubMed ID: 21906804 [Abstract] [Full Text] [Related]
13. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles. Liu Q, Zhang J, Xia W, Gu H. Nanoscale; 2012 Jun 07; 4(11):3415-21. PubMed ID: 22543531 [Abstract] [Full Text] [Related]
14. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles. Zhang J, Li X, Rosenholm JM, Gu HC. J Colloid Interface Sci; 2011 Sep 01; 361(1):16-24. PubMed ID: 21689824 [Abstract] [Full Text] [Related]
15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849 [Abstract] [Full Text] [Related]
16. Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles. Urata C, Aoyama Y, Tonegawa A, Yamauchi Y, Kuroda K. Chem Commun (Camb); 2009 Sep 14; (34):5094-6. PubMed ID: 20448957 [Abstract] [Full Text] [Related]
17. Anionic-cationic switchable amphoteric monodisperse mesoporous silica nanoparticles. Ma Y, Xing L, Zheng H, Che S. Langmuir; 2011 Jan 18; 27(2):517-20. PubMed ID: 21166445 [Abstract] [Full Text] [Related]
18. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. He Q, Gao Y, Zhang L, Zhang Z, Gao F, Ji X, Li Y, Shi J. Biomaterials; 2011 Oct 18; 32(30):7711-20. PubMed ID: 21816467 [Abstract] [Full Text] [Related]
19. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy. Lai CH, Lai NC, Chuang YJ, Chou FI, Yang CM, Lin CC. Nanoscale; 2013 Oct 07; 5(19):9412-8. PubMed ID: 23958787 [Abstract] [Full Text] [Related]
20. Folic acid-functionalized mesoporous silica nanospheres hybridized with AIE luminogens for targeted cancer cell imaging. Wang Z, Xu B, Zhang L, Zhang J, Ma T, Zhang J, Fu X, Tian W. Nanoscale; 2013 Mar 07; 5(5):2065-72. PubMed ID: 23376958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]